| cellular process (GO:0009987) | 0.26 | 27 | KPTN, GPT2, TRAPPC9, TUSC3, HNMT, NSUN2, CC2D1A, PGAP1, NDST1, PRSS12, ST3GAL3, ANK3, CRADD, MAN1B1, TAF2, FBXO31, MED23, HERC2, CRBN, ADAT3, FMN2, PIGG, LMAN2L, KIAA1033, TECR, GRIK2, EDC3 |
| metabolic process (GO:0008152) | 0.58 | 20 | FBXO31, CRBN, ST3GAL3, GPT2, MAN1B1, NDST1, MED23, TUSC3, TECR, ADAT3, CC2D1A, PRSS12, HERC2, EDC3, PIGG, HNMT, METTL23, NSUN2, PGAP1, TAF2 |
| single-organism process (GO:0044699) | 0.48 | 20 | FBXO31, ST3GAL3, GPT2, NDST1, HNMT, TUSC3, PGAP1, HERC2, TECR, GRIK2, KPTN, PRSS12, CRADD, SLC6A17, PIGG, FMN2, ANK3, NSUN2, TRAPPC9, MAN1B1 |
| primary metabolic process (GO:0044238) | 0.69 | 19 | PIGG, CRBN, FBXO31, GPT2, NDST1, TUSC3, PGAP1, HERC2, TECR, ADAT3, CC2D1A, PRSS12, MAN1B1, ST3GAL3, HNMT, EDC3, NSUN2, MED23, TAF2 |
| organic substance metabolic process (GO:0071704) | 0.63 | 19 | FBXO31, CC2D1A, ST3GAL3, GPT2, HNMT, NDST1, PGAP1, TUSC3, TECR, ADAT3, PRSS12, HERC2, MAN1B1, PIGG, CRBN, EDC3, NSUN2, MED23, TAF2 |
| single-organism cellular process (GO:0044763) | 0.65 | 18 | FMN2, ST3GAL3, GPT2, HNMT, NDST1, TRAPPC9, CRADD, TUSC3, TECR, GRIK2, KPTN, PRSS12, FBXO31, PIGG, ANK3, NSUN2, PGAP1, MAN1B1 |
| cellular metabolic process (GO:0044237) | 0.69 | 18 | FBXO31, CRBN, ST3GAL3, GPT2, NDST1, TUSC3, PGAP1, HERC2, CC2D1A, ADAT3, TECR, MAN1B1, PIGG, HNMT, EDC3, NSUN2, MED23, TAF2 |
| macromolecule metabolic process (GO:0043170) | 0.83 | 16 | CRBN, PIGG, FBXO31, NDST1, TUSC3, PGAP1, HERC2, CC2D1A, ADAT3, PRSS12, MAN1B1, ST3GAL3, EDC3, NSUN2, MED23, TAF2 |
| cellular macromolecule metabolic process (GO:0044260) | 0.93 | 15 | CRBN, ST3GAL3, FBXO31, NDST1, PGAP1, TUSC3, CC2D1A, ADAT3, HERC2, MAN1B1, PIGG, EDC3, NSUN2, MED23, TAF2 |
| biological regulation (GO:0065007) | 0.39 | 13 | CRBN, HNMT, FBXO31, HERC2, MED23, NDST1, CC2D1A, GRIK2, FMN2, ANK3, CRADD, TRAPPC9, TAF2 |
| nitrogen compound metabolic process (GO:0006807) | 1.13 | 12 | CC2D1A, HNMT, GPT2, HERC2, MED23, NDST1, ADAT3, EDC3, ST3GAL3, NSUN2, PGAP1, TAF2 |
| regulation of biological process (GO:0050789) | 0.45 | 12 | CRBN, HNMT, FBXO31, MED23, NDST1, CC2D1A, GRIK2, FMN2, ANK3, CRADD, TRAPPC9, TAF2 |
| regulation of cellular process (GO:0050794) | 0.5 | 12 | CRBN, HNMT, FBXO31, MED23, NDST1, CC2D1A, GRIK2, FMN2, ANK3, CRADD, TRAPPC9, TAF2 |
| protein metabolic process (GO:0019538) | 1.45 | 11 | CRBN, PIGG, FBXO31, TUSC3, PGAP1, NDST1, PRSS12, HERC2, MAN1B1, ST3GAL3, TAF2 |
| macromolecule modification (GO:0043412) | 1.73 | 11 | CRBN, ST3GAL3, FBXO31, TUSC3, PGAP1, NDST1, ADAT3, HERC2, PIGG, NSUN2, MAN1B1 |
| establishment of localization (GO:0051234) | 1.48 | 10 | KIAA1033, HERC2, PGAP1, TUSC3, FMN2, GRIK2, PRSS12, SLC6A17, ANK3, LMAN2L |
| localization (GO:0051179) | 1.4 | 10 | KIAA1033, HERC2, PGAP1, TUSC3, FMN2, GRIK2, PRSS12, SLC6A17, ANK3, LMAN2L |
| transport (GO:0006810) | 1.51 | 10 | KIAA1033, HERC2, PGAP1, TUSC3, FMN2, GRIK2, PRSS12, SLC6A17, ANK3, LMAN2L |
| cellular protein metabolic process (GO:0044267) | 1.63 | 9 | CRBN, ST3GAL3, FBXO31, NDST1, HERC2, PGAP1, TUSC3, PIGG, MAN1B1 |
| single-organism metabolic process (GO:0044710) | 1.63 | 9 | ST3GAL3, GPT2, TUSC3, PGAP1, NDST1, HNMT, TECR, PIGG, MAN1B1 |
| organic substance biosynthetic process (GO:1901576) | 1.34 | 9 | CC2D1A, ST3GAL3, GPT2, MED23, NDST1, TECR, PIGG, PGAP1, TAF2 |
| response to stimulus (GO:0050896) | 1.22 | 9 | HNMT, FBXO31, NDST1, HERC2, GRIK2, FMN2, ANK3, CRADD, TAF2 |
| cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 9 | CC2D1A, MED23, HERC2, ADAT3, EDC3, ST3GAL3, NSUN2, PGAP1, TAF2 |
| cellular protein modification process (GO:0006464) | 1.79 | 9 | CRBN, ST3GAL3, FBXO31, NDST1, HERC2, PGAP1, TUSC3, PIGG, MAN1B1 |
| cellular biosynthetic process (GO:0044249) | 1.37 | 9 | CC2D1A, ST3GAL3, GPT2, MED23, NDST1, TECR, PIGG, PGAP1, TAF2 |
| biosynthetic process (GO:0009058) | 1.32 | 9 | CC2D1A, PIGG, GPT2, MED23, NDST1, TECR, ST3GAL3, PGAP1, TAF2 |
| protein modification process (GO:0036211) | 1.79 | 9 | CRBN, ST3GAL3, FBXO31, NDST1, HERC2, PGAP1, TUSC3, PIGG, MAN1B1 |
| cellular component organization (GO:0016043) | 1.24 | 9 | KIAA1033, KPTN, TRAPPC9, GRIK2, FMN2, TAF2, ANK3, NSUN2, EDC3 |
| positive regulation of biological process (GO:0048518) | 1.2 | 9 | CC2D1A, HNMT, FBXO31, TRAPPC9, GRIK2, FMN2, ANK3, CRADD, TAF2 |
| cellular component organization or biogenesis (GO:0071840) | 1.22 | 9 | KIAA1033, KPTN, TRAPPC9, GRIK2, FMN2, TAF2, ANK3, NSUN2, EDC3 |
| developmental process (GO:0032502) | 1.36 | 8 | HNMT, TRAPPC9, NDST1, SLC6A17, FMN2, ANK3, NSUN2, PGAP1 |
| nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 8 | CC2D1A, PGAP1, HERC2, ADAT3, TAF2, NSUN2, MED23, EDC3 |
| nucleic acid metabolic process (GO:0090304) | 1.46 | 8 | CC2D1A, PGAP1, HERC2, ADAT3, TAF2, NSUN2, MED23, EDC3 |
| multicellular organismal process (GO:0032501) | 1.45 | 8 | KPTN, TUSC3, PGAP1, NDST1, GRIK2, FMN2, HNMT, LINS1 |
| regulation of metabolic process (GO:0019222) | 1.02 | 8 | CC2D1A, TRAPPC9, GRIK2, FMN2, ANK3, CRADD, MED23, TAF2 |
| regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 8 | CC2D1A, TRAPPC9, GRIK2, FMN2, ANK3, CRADD, MED23, TAF2 |
| cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 8 | CC2D1A, PGAP1, HERC2, ADAT3, TAF2, NSUN2, MED23, EDC3 |
| single-organism developmental process (GO:0044767) | 1.49 | 8 | HNMT, PGAP1, NDST1, SLC6A17, FMN2, ANK3, NSUN2, TRAPPC9 |
| organic substance transport (GO:0071702) | 2.15 | 8 | KIAA1033, PGAP1, HERC2, GRIK2, FMN2, SLC6A17, ANK3, LMAN2L |
| heterocycle metabolic process (GO:0046483) | 1.31 | 8 | CC2D1A, PGAP1, HERC2, ADAT3, TAF2, NSUN2, MED23, EDC3 |
| organic cyclic compound metabolic process (GO:1901360) | 1.26 | 8 | CC2D1A, PGAP1, HERC2, ADAT3, TAF2, NSUN2, MED23, EDC3 |
| positive regulation of cellular process (GO:0048522) | 1.3 | 8 | CC2D1A, HNMT, FBXO31, GRIK2, FMN2, ANK3, CRADD, TAF2 |
| protein localization (GO:0008104) | 2.36 | 7 | KIAA1033, PGAP1, HERC2, GRIK2, FMN2, ANK3, LMAN2L |
| regulation of primary metabolic process (GO:0080090) | 1.08 | 7 | CC2D1A, MED23, GRIK2, FMN2, CRADD, TRAPPC9, TAF2 |
| anatomical structure development (GO:0048856) | 1.58 | 7 | TRAPPC9, NDST1, SLC6A17, FMN2, HNMT, NSUN2, PGAP1 |
| establishment of protein localization (GO:0045184) | 2.53 | 7 | KIAA1033, PGAP1, HERC2, GRIK2, FMN2, ANK3, LMAN2L |
| response to stress (GO:0006950) | 1.8 | 7 | FBXO31, NDST1, HERC2, GRIK2, FMN2, HNMT, CRADD |
| protein transport (GO:0015031) | 2.62 | 7 | KIAA1033, PGAP1, HERC2, GRIK2, FMN2, ANK3, LMAN2L |
| negative regulation of biological process (GO:0048519) | 1.33 | 7 | CRBN, FBXO31, CC2D1A, GRIK2, FMN2, ANK3, CRADD |
| macromolecule localization (GO:0033036) | 2.34 | 7 | KIAA1033, PGAP1, HERC2, GRIK2, FMN2, ANK3, LMAN2L |
| negative regulation of cellular process (GO:0048523) | 1.41 | 7 | CRBN, FBXO31, CC2D1A, GRIK2, FMN2, ANK3, CRADD |
| RNA metabolic process (GO:0016070) | 1.59 | 6 | CC2D1A, MED23, ADAT3, TAF2, NSUN2, EDC3 |
| organelle organization (GO:0006996) | 2.02 | 6 | KIAA1033, TRAPPC9, FMN2, ANK3, NSUN2, EDC3 |
| organic substance catabolic process (GO:1901575) | 2.45 | 6 | CRBN, GPT2, FBXO31, MAN1B1, HNMT, EDC3 |
| single-organism biosynthetic process (GO:0044711) | 2.8 | 6 | ST3GAL3, GPT2, PGAP1, NDST1, TECR, PIGG |
| regulation of cellular metabolic process (GO:0031323) | 1.07 | 6 | CC2D1A, TRAPPC9, GRIK2, CRADD, MED23, TAF2 |
| cellular catabolic process (GO:0044248) | 2.62 | 6 | CRBN, GPT2, FBXO31, MAN1B1, HNMT, EDC3 |
| cell cycle process (GO:0022402) | 2.75 | 6 | FBXO31, NSUN2, FMN2, ANK3, CRADD, TAF2 |
| signal transduction (GO:0007165) | 1.28 | 6 | CC2D1A, NDST1, GRIK2, FMN2, ANK3, CRADD |
| catabolic process (GO:0009056) | 2.38 | 6 | CRBN, GPT2, FBXO31, MAN1B1, HNMT, EDC3 |
| single-organism localization (GO:1902578) | 2.09 | 6 | PGAP1, PRSS12, GRIK2, FMN2, SLC6A17, ANK3 |
| cellular response to stimulus (GO:0051716) | 1.97 | 5 | CRADD, FMN2, HERC2, FBXO31, ANK3 |
| cellular component assembly (GO:0022607) | 2.14 | 5 | FMN2, TRAPPC9, ANK3, EDC3, TAF2 |
| single-multicellular organism process (GO:0044707) | 1.78 | 5 | FMN2, PGAP1, NDST1, HNMT, GRIK2 |
| intracellular transport (GO:0046907) | 2.67 | 5 | LMAN2L, FMN2, HERC2, GRIK2, ANK3 |
| mitotic cell cycle process (GO:1903047) | 3.12 | 5 | FBXO31, CRADD, NSUN2, TAF2, ANK3 |
| regulation of cellular component organization (GO:0051128) | 2.01 | 5 | FBXO31, CRBN, HNMT, FMN2, ANK3 |
| macromolecule biosynthetic process (GO:0009059) | 1.61 | 5 | MED23, NDST1, CC2D1A, ST3GAL3, TAF2 |
| positive regulation of molecular function (GO:0044093) | 2.23 | 5 | CRADD, TRAPPC9, HERC2, CRBN, ANK3 |
| establishment of localization in cell (GO:0051649) | 2.47 | 5 | ANK3, FMN2, HERC2, GRIK2, LMAN2L |
| proteolysis (GO:0006508) | 2.73 | 5 | FBXO31, CRBN, PRSS12, MAN1B1, TAF2 |
| regulation of molecular function (GO:0065009) | 1.78 | 5 | HERC2, TRAPPC9, CRADD, CRBN, ANK3 |
| regulation of cell communication (GO:0010646) | 1.73 | 5 | CC2D1A, CRADD, ANK3, GRIK2, TAF2 |
| regulation of gene expression (GO:0010468) | 1.37 | 5 | TRAPPC9, TAF2, MED23, ANK3, CC2D1A |
| cellular localization (GO:0051641) | 2.32 | 5 | LMAN2L, FMN2, HERC2, ANK3, GRIK2 |
| regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 4 | TRAPPC9, MED23, TAF2, CC2D1A |
| regulation of response to stimulus (GO:0048583) | 1.54 | 4 | CC2D1A, CRADD, TAF2, GRIK2 |
| cellular macromolecule biosynthetic process (GO:0034645) | 1.66 | 4 | MED23, NDST1, CC2D1A, TAF2 |
| regulation of signaling (GO:0023051) | 1.72 | 4 | CC2D1A, CRADD, TAF2, GRIK2 |
| positive regulation of cell communication (GO:0010647) | 2.41 | 4 | CC2D1A, CRADD, ANK3, GRIK2 |
| carbohydrate metabolic process (GO:0005975) | 3.26 | 4 | TUSC3, NDST1, MAN1B1, ST3GAL3 |
| cellular macromolecule catabolic process (GO:0044265) | 3.19 | 4 | FBXO31, CRBN, EDC3, MAN1B1 |
| cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 4 | MED23, CC2D1A, ST3GAL3, TAF2 |
| regulation of signal transduction (GO:0009966) | 1.84 | 4 | CC2D1A, CRADD, TAF2, GRIK2 |
| cellular developmental process (GO:0048869) | 1.82 | 4 | TRAPPC9, NSUN2, FMN2, ANK3 |
| regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 4 | TRAPPC9, MED23, TAF2, CC2D1A |
| lipid biosynthetic process (GO:0008610) | 3.49 | 4 | PIGG, PGAP1, TECR, ST3GAL3 |
| positive regulation of cellular component organization (GO:0051130) | 2.68 | 4 | FMN2, HNMT, FBXO31, ANK3 |
| lipid metabolic process (GO:0006629) | 2.68 | 4 | PIGG, PGAP1, TECR, ST3GAL3 |
| regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 4 | TRAPPC9, MED23, TAF2, CC2D1A |
| neurological system process (GO:0050877) | 2.64 | 4 | PGAP1, TUSC3, LINS1, KPTN |
| regulation of biosynthetic process (GO:0009889) | 1.37 | 4 | TRAPPC9, MED23, TAF2, CC2D1A |
| regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 4 | TRAPPC9, MED23, TAF2, CC2D1A |
| cellular response to DNA damage stimulus (GO:0006974) | 3.17 | 4 | CRADD, FMN2, HERC2, FBXO31 |
| single-organism transport (GO:0044765) | 2.18 | 4 | ANK3, PGAP1, PRSS12, SLC6A17 |
| regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 4 | TRAPPC9, MED23, TAF2, CC2D1A |
| regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 4 | TRAPPC9, MED23, TAF2, CC2D1A |
| single-organism carbohydrate metabolic process (GO:0044723) | 3.42 | 4 | NDST1, TUSC3, ST3GAL3, MAN1B1 |
| response to chemical (GO:0042221) | 1.98 | 4 | FMN2, ANK3, HNMT, TAF2 |
| cellular lipid metabolic process (GO:0044255) | 2.92 | 4 | PIGG, PGAP1, TECR, ST3GAL3 |
| regulation of localization (GO:0032879) | 1.94 | 4 | FBXO31, CRBN, HNMT, ANK3 |
| macromolecule catabolic process (GO:0009057) | 3.0 | 4 | FBXO31, CRBN, EDC3, MAN1B1 |
| system process (GO:0003008) | 2.3 | 4 | PGAP1, TUSC3, LINS1, KPTN |
| organonitrogen compound metabolic process (GO:1901564) | 2.32 | 4 | GPT2, NDST1, HNMT, ST3GAL3 |
| vesicle-mediated transport (GO:0016192) | 2.72 | 4 | ANK3, FMN2, PRSS12, LMAN2L |
| carbohydrate derivative biosynthetic process (GO:1901137) | 3.73 | 4 | PGAP1, NDST1, PIGG, ST3GAL3 |
| carbohydrate derivative metabolic process (GO:1901135) | 3.07 | 4 | PGAP1, NDST1, PIGG, ST3GAL3 |
| regulation of RNA metabolic process (GO:0051252) | 1.52 | 4 | TRAPPC9, MED23, TAF2, CC2D1A |
| regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 4 | TRAPPC9, MED23, TAF2, CC2D1A |
| regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 4 | TRAPPC9, MED23, TAF2, CC2D1A |
| cellular response to stress (GO:0033554) | 2.51 | 4 | HERC2, FMN2, CRADD, FBXO31 |
| positive regulation of metabolic process (GO:0009893) | 1.74 | 3 | CRADD, TAF2, ANK3 |
| macromolecular complex subunit organization (GO:0043933) | 2.14 | 3 | TRAPPC9, TAF2, EDC3 |
| regulation of transport (GO:0051049) | 2.24 | 3 | CRBN, ANK3, HNMT |
| carboxylic acid metabolic process (GO:0019752) | 3.12 | 3 | TECR, GPT2, HNMT |
| movement of cell or subcellular component (GO:0006928) | 2.61 | 3 | FMN2, KPTN, ANK3 |
| positive regulation of signaling (GO:0023056) | 2.41 | 3 | CC2D1A, CRADD, GRIK2 |
| nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 3 | MED23, CC2D1A, TAF2 |
| small molecule metabolic process (GO:0044281) | 2.38 | 3 | TECR, GPT2, HNMT |
| cell surface receptor signaling pathway (GO:0007166) | 2.09 | 3 | CRADD, NDST1, GRIK2 |
| glycolipid biosynthetic process (GO:0009247) | 5.6 | 3 | PGAP1, PIGG, ST3GAL3 |
| intracellular signal transduction (GO:0035556) | 2.39 | 3 | CRADD, FMN2, NDST1 |
| regulation of cell death (GO:0010941) | 2.43 | 3 | FMN2, CRADD, GRIK2 |
| organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 3 | MED23, CC2D1A, TAF2 |
| modification-dependent macromolecule catabolic process (GO:0043632) | 3.69 | 3 | CRBN, FBXO31, MAN1B1 |
| nucleic acid-templated transcription (GO:0097659) | 1.91 | 3 | MED23, CC2D1A, TAF2 |
| RNA biosynthetic process (GO:0032774) | 1.84 | 3 | MED23, CC2D1A, TAF2 |
| positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 3 | CRADD, TAF2, ANK3 |
| protein glycosylation (GO:0006486) | 4.2 | 3 | TUSC3, ST3GAL3, MAN1B1 |
| regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 3 | MED23, CC2D1A, TAF2 |
| regulation of apoptotic process (GO:0042981) | 2.5 | 3 | FMN2, CRADD, GRIK2 |
| intracellular protein transport (GO:0006886) | 3.2 | 3 | HERC2, ANK3, GRIK2 |
| regulation of protein metabolic process (GO:0051246) | 1.93 | 3 | FMN2, CRADD, GRIK2 |
| peptidyl-amino acid modification (GO:0018193) | 2.98 | 3 | TUSC3, HERC2, ST3GAL3 |
| macromolecular complex assembly (GO:0065003) | 2.55 | 3 | TRAPPC9, TAF2, EDC3 |
| protein modification by small protein conjugation (GO:0032446) | 3.1 | 3 | CRBN, HERC2, FBXO31 |
| regulation of programmed cell death (GO:0043067) | 2.49 | 3 | FMN2, CRADD, GRIK2 |
| animal organ development (GO:0048513) | 2.53 | 3 | NDST1, HNMT, SLC6A17 |
| organic acid metabolic process (GO:0006082) | 3.01 | 3 | TECR, GPT2, HNMT |
| membrane lipid biosynthetic process (GO:0046467) | 4.99 | 3 | PGAP1, PIGG, ST3GAL3 |
| methylation (GO:0032259) | 4.06 | 3 | NSUN2, HNMT, METTL23 |
| glycolipid metabolic process (GO:0006664) | 5.01 | 3 | PGAP1, PIGG, ST3GAL3 |
| heterocycle biosynthetic process (GO:0018130) | 1.7 | 3 | MED23, CC2D1A, TAF2 |
| liposaccharide metabolic process (GO:1903509) | 4.98 | 3 | PGAP1, PIGG, ST3GAL3 |
| membrane lipid metabolic process (GO:0006643) | 4.51 | 3 | PGAP1, PIGG, ST3GAL3 |
| response to abiotic stimulus (GO:0009628) | 2.8 | 3 | FMN2, CRADD, HNMT |
| glycosylation (GO:0070085) | 4.16 | 3 | TUSC3, MAN1B1, ST3GAL3 |
| ion transport (GO:0006811) | 2.66 | 3 | TUSC3, SLC6A17, GRIK2 |
| modification-dependent protein catabolic process (GO:0019941) | 3.71 | 3 | CRBN, FBXO31, MAN1B1 |
| reproductive process (GO:0022414) | 2.55 | 3 | NSUN2, FMN2, HERC2 |
| macromolecule glycosylation (GO:0043413) | 4.2 | 3 | TUSC3, MAN1B1, ST3GAL3 |
| protein catabolic process (GO:0030163) | 3.93 | 3 | CRBN, FBXO31, MAN1B1 |
| oxoacid metabolic process (GO:0043436) | 3.12 | 3 | TECR, GPT2, HNMT |
| regulation of intracellular signal transduction (GO:1902531) | 2.31 | 3 | CC2D1A, TAF2, GRIK2 |
| transmembrane transport (GO:0055085) | 2.72 | 3 | TUSC3, SLC6A17, GRIK2 |
| protein modification by small protein conjugation or removal (GO:0070647) | 2.95 | 3 | CRBN, HERC2, FBXO31 |
| proteolysis involved in cellular protein catabolic process (GO:0051603) | 3.59 | 3 | CRBN, FBXO31, MAN1B1 |
| single organism reproductive process (GO:0044702) | 2.73 | 3 | HERC2, FMN2, NSUN2 |
| regulation of biological quality (GO:0065008) | 1.68 | 3 | FMN2, ANK3, GRIK2 |
| organonitrogen compound biosynthetic process (GO:1901566) | 2.85 | 3 | NDST1, GPT2, ST3GAL3 |
| sulfur compound biosynthetic process (GO:0044272) | 4.5 | 3 | TECR, NDST1, ST3GAL3 |
| proteasomal protein catabolic process (GO:0010498) | 4.12 | 3 | CRBN, FBXO31, MAN1B1 |
| protein ubiquitination (GO:0016567) | 3.28 | 3 | CRBN, HERC2, FBXO31 |
| phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 3 | PGAP1, NDST1, PIGG |
| ubiquitin-dependent protein catabolic process (GO:0006511) | 3.72 | 3 | CRBN, FBXO31, MAN1B1 |
| sulfur compound metabolic process (GO:0006790) | 3.87 | 3 | TECR, NDST1, ST3GAL3 |
| transcription, DNA-templated (GO:0006351) | 1.91 | 3 | MED23, CC2D1A, TAF2 |
| phosphorus metabolic process (GO:0006793) | 2.15 | 3 | PGAP1, NDST1, PIGG |
| aromatic compound biosynthetic process (GO:0019438) | 1.7 | 3 | MED23, CC2D1A, TAF2 |
| single-organism cellular localization (GO:1902580) | 3.16 | 3 | FMN2, ANK3, GRIK2 |
| proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161) | 4.16 | 3 | CRBN, FBXO31, MAN1B1 |
| regulation of intracellular protein transport (GO:0033157) | 3.8 | 2 | HNMT, ANK3 |
| positive regulation of intracellular transport (GO:0032388) | 4.08 | 2 | HNMT, ANK3 |
| regulation of intracellular transport (GO:0032386) | 3.58 | 2 | HNMT, ANK3 |
| positive regulation of response to stimulus (GO:0048584) | 2.18 | 2 | CC2D1A, CRADD |
| cell development (GO:0048468) | 3.28 | 2 | FMN2, NSUN2 |
| RNA modification (GO:0009451) | 4.94 | 2 | NSUN2, ADAT3 |
| membrane organization (GO:0061024) | 3.04 | 2 | ANK3, GRIK2 |
| small molecule catabolic process (GO:0044282) | 3.99 | 2 | GPT2, HNMT |
| small molecule biosynthetic process (GO:0044283) | 3.79 | 2 | TECR, GPT2 |
| inorganic ion homeostasis (GO:0098771) | 3.43 | 2 | ANK3, GRIK2 |
| regulation of ion transmembrane transport (GO:0034765) | 3.77 | 2 | CRBN, ANK3 |
| negative regulation of ion transmembrane transport (GO:0034766) | 5.47 | 2 | CRBN, ANK3 |
| regulation of transmembrane transport (GO:0034762) | 3.74 | 2 | CRBN, ANK3 |
| negative regulation of transmembrane transport (GO:0034763) | 5.38 | 2 | CRBN, ANK3 |
| single-organism catabolic process (GO:0044712) | 3.21 | 2 | GPT2, HNMT |
| negative regulation of cell cycle (GO:0045786) | 3.67 | 2 | CRADD, FBXO31 |
| cellular macromolecule localization (GO:0070727) | 3.1 | 2 | ANK3, GRIK2 |
| positive regulation of signal transduction (GO:0009967) | 2.5 | 2 | CC2D1A, CRADD |
| peptidyl-asparagine modification (GO:0018196) | 6.07 | 2 | TUSC3, ST3GAL3 |
| phosphatidylinositol biosynthetic process (GO:0006661) | 4.94 | 2 | PGAP1, PIGG |
| ncRNA processing (GO:0034470) | 3.77 | 2 | NSUN2, ADAT3 |
| negative regulation of transport (GO:0051051) | 3.6 | 2 | CRBN, ANK3 |
| positive regulation of transport (GO:0051050) | 2.9 | 2 | HNMT, ANK3 |
| sensory perception of sound (GO:0007605) | 4.82 | 2 | PGAP1, KPTN |
| negative regulation of cell death (GO:0060548) | 2.95 | 2 | FMN2, GRIK2 |
| sensory perception (GO:0007600) | 2.93 | 2 | PGAP1, KPTN |
| germ cell development (GO:0007281) | 4.75 | 2 | FMN2, NSUN2 |
| developmental process involved in reproduction (GO:0003006) | 3.36 | 2 | FMN2, NSUN2 |
| phosphatidylinositol metabolic process (GO:0046488) | 4.46 | 2 | PGAP1, PIGG |
| protein localization to membrane (GO:0072657) | 3.95 | 2 | ANK3, GRIK2 |
| glycerolipid metabolic process (GO:0046486) | 3.91 | 2 | PGAP1, PIGG |
| response to organic substance (GO:0010033) | 2.2 | 2 | TAF2, HNMT |
| cytokinesis (GO:0000910) | 5.22 | 2 | FMN2, ANK3 |
| organonitrogen compound catabolic process (GO:1901565) | 3.91 | 2 | GPT2, HNMT |
| organic acid catabolic process (GO:0016054) | 4.44 | 2 | GPT2, HNMT |
| positive regulation of organelle organization (GO:0010638) | 3.38 | 2 | FMN2, HNMT |
| organic acid biosynthetic process (GO:0016053) | 4.26 | 2 | TECR, GPT2 |
| protein N-linked glycosylation via asparagine (GO:0018279) | 6.09 | 2 | TUSC3, ST3GAL3 |
| organophosphate metabolic process (GO:0019637) | 3.04 | 2 | PGAP1, PIGG |
| chemical homeostasis (GO:0048878) | 2.97 | 2 | ANK3, GRIK2 |
| regulation of membrane potential (GO:0042391) | 3.89 | 2 | ANK3, GRIK2 |
| negative regulation of metabolic process (GO:0009892) | 1.93 | 2 | CC2D1A, FMN2 |
| regulation of protein targeting (GO:1903533) | 4.0 | 2 | HNMT, ANK3 |
| neuronal action potential (GO:0019228) | 6.4 | 2 | ANK3, GRIK2 |
| cellular amino acid catabolic process (GO:0009063) | 5.37 | 2 | GPT2, HNMT |
| action potential (GO:0001508) | 5.42 | 2 | ANK3, GRIK2 |
| positive regulation of gene expression (GO:0010628) | 2.35 | 2 | TAF2, ANK3 |
| cytoskeleton-dependent cytokinesis (GO:0061640) | 6.2 | 2 | FMN2, ANK3 |
| ncRNA metabolic process (GO:0034660) | 3.44 | 2 | NSUN2, ADAT3 |
| positive regulation of protein transport (GO:0051222) | 3.61 | 2 | HNMT, ANK3 |
| regulation of protein transport (GO:0051223) | 3.12 | 2 | HNMT, ANK3 |
| regulation of mitotic cell cycle (GO:0007346) | 3.71 | 2 | CRADD, FBXO31 |
| anatomical structure morphogenesis (GO:0009653) | 2.53 | 2 | NDST1, ANK3 |
| ER to Golgi vesicle-mediated transport (GO:0006888) | 4.7 | 2 | LMAN2L, ANK3 |
| positive regulation of hydrolase activity (GO:0051345) | 2.91 | 2 | CRADD, HERC2 |
| positive regulation of cellular protein localization (GO:1903829) | 3.85 | 2 | HNMT, ANK3 |
| transcription initiation from RNA polymerase II promoter (GO:0006367) | 4.7 | 2 | MED23, TAF2 |
| regulation of establishment of protein localization (GO:0070201) | 3.02 | 2 | HNMT, ANK3 |
| respiratory gaseous exchange (GO:0007585) | 5.86 | 2 | NDST1, HNMT |
| sensory perception of mechanical stimulus (GO:0050954) | 4.79 | 2 | PGAP1, KPTN |
| regulation of catalytic activity (GO:0050790) | 1.97 | 2 | CRADD, HERC2 |
| regulation of cellular component biogenesis (GO:0044087) | 3.08 | 2 | CRBN, FMN2 |
| defense response (GO:0006952) | 2.78 | 2 | NDST1, GRIK2 |
| programmed cell death (GO:0012501) | 3.1 | 2 | CRADD, GRIK2 |
| single-organism membrane organization (GO:0044802) | 3.19 | 2 | ANK3, GRIK2 |
| negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 5.17 | 2 | CRADD, FBXO31 |
| regulation of protein complex assembly (GO:0043254) | 3.83 | 2 | CRBN, FMN2 |
| organophosphate biosynthetic process (GO:0090407) | 3.67 | 2 | PGAP1, PIGG |
| negative regulation of cell cycle phase transition (GO:1901988) | 4.74 | 2 | CRADD, FBXO31 |
| regulation of hydrolase activity (GO:0051336) | 2.53 | 2 | CRADD, HERC2 |
| brain development (GO:0007420) | 4.24 | 2 | HNMT, SLC6A17 |
| phospholipid biosynthetic process (GO:0008654) | 4.39 | 2 | PGAP1, PIGG |
| carboxylic acid biosynthetic process (GO:0046394) | 4.32 | 2 | TECR, GPT2 |
| carboxylic acid catabolic process (GO:0046395) | 4.58 | 2 | GPT2, HNMT |
| cognition (GO:0050890) | 4.2 | 2 | TUSC3, LINS1 |
| DNA-templated transcription, initiation (GO:0006352) | 4.49 | 2 | MED23, TAF2 |
| aminoglycan metabolic process (GO:0006022) | 4.62 | 2 | NDST1, ST3GAL3 |
| aminoglycan biosynthetic process (GO:0006023) | 5.06 | 2 | NDST1, ST3GAL3 |
| glycosaminoglycan biosynthetic process (GO:0006024) | 5.07 | 2 | NDST1, ST3GAL3 |
| positive regulation of catalytic activity (GO:0043085) | 2.4 | 2 | CRADD, HERC2 |
| regulation of organelle organization (GO:0033043) | 2.72 | 2 | FMN2, HNMT |
| ion homeostasis (GO:0050801) | 3.42 | 2 | ANK3, GRIK2 |
| metal ion homeostasis (GO:0055065) | 3.61 | 2 | ANK3, GRIK2 |
| oligosaccharide metabolic process (GO:0009311) | 5.54 | 2 | MAN1B1, ST3GAL3 |
| regulation of cellular protein localization (GO:1903827) | 3.43 | 2 | HNMT, ANK3 |
| negative regulation of mitotic cell cycle phase transition (GO:1901991) | 4.82 | 2 | CRADD, FBXO31 |
| regulation of mitotic cell cycle phase transition (GO:1901990) | 4.23 | 2 | CRADD, FBXO31 |
| cellular response to chemical stimulus (GO:0070887) | 2.57 | 2 | FMN2, ANK3 |
| glycosaminoglycan metabolic process (GO:0030203) | 4.67 | 2 | NDST1, ST3GAL3 |
| positive regulation of establishment of protein localization (GO:1904951) | 3.49 | 2 | HNMT, ANK3 |
| response to organic cyclic compound (GO:0014070) | 3.07 | 2 | HNMT, TAF2 |
| regulation of protein localization (GO:0032880) | 2.88 | 2 | HNMT, ANK3 |
| divalent inorganic cation homeostasis (GO:0072507) | 3.9 | 2 | ANK3, GRIK2 |
| regulation of cell cycle process (GO:0010564) | 3.5 | 2 | CRADD, FBXO31 |
| GPI anchor metabolic process (GO:0006505) | 6.23 | 2 | PGAP1, PIGG |
| GPI anchor biosynthetic process (GO:0006506) | 6.26 | 2 | PGAP1, PIGG |
| regulation of cell cycle phase transition (GO:1901987) | 4.15 | 2 | CRADD, FBXO31 |
| apoptotic process (GO:0006915) | 3.14 | 2 | CRADD, GRIK2 |
| phospholipid metabolic process (GO:0006644) | 3.88 | 2 | PGAP1, PIGG |
| tRNA processing (GO:0008033) | 4.96 | 2 | NSUN2, ADAT3 |
| multicellular organismal reproductive process (GO:0048609) | 3.35 | 2 | FMN2, HERC2 |
| negative regulation of ion transport (GO:0043271) | 4.94 | 2 | CRBN, ANK3 |
| cation homeostasis (GO:0055080) | 3.46 | 2 | ANK3, GRIK2 |
| meiotic cell cycle process (GO:1903046) | 4.71 | 2 | FMN2, NSUN2 |
| cell cycle (GO:0007049) | 3.14 | 2 | NSUN2, FBXO31 |
| regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 2 | CRADD, GRIK2 |
| regulation of G1/S transition of mitotic cell cycle (GO:2000045) | 4.81 | 2 | CRADD, FBXO31 |
| negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 2 | CC2D1A, FMN2 |
| glycerophospholipid biosynthetic process (GO:0046474) | 4.62 | 2 | PGAP1, PIGG |
| negative regulation of cell cycle G1/S phase transition (GO:1902807) | 5.14 | 2 | CRADD, FBXO31 |
| glycerophospholipid metabolic process (GO:0006650) | 4.13 | 2 | PGAP1, PIGG |
| regulation of cellular localization (GO:0060341) | 3.03 | 2 | HNMT, ANK3 |
| positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 2 | CRADD, TAF2 |
| mucopolysaccharide metabolic process (GO:1903510) | 5.05 | 2 | NDST1, ST3GAL3 |
| homeostatic process (GO:0042592) | 2.61 | 2 | ANK3, GRIK2 |
| nucleic acid phosphodiester bond hydrolysis (GO:0090305) | 4.12 | 2 | PGAP1, EDC3 |
| negative regulation of cell cycle process (GO:0010948) | 4.37 | 2 | CRADD, FBXO31 |
| cellular macromolecular complex assembly (GO:0034622) | 3.18 | 2 | TAF2, EDC3 |
| positive regulation of cell death (GO:0010942) | 3.32 | 2 | CRADD, GRIK2 |
| cell death (GO:0008219) | 3.05 | 2 | CRADD, GRIK2 |
| gamete generation (GO:0007276) | 3.61 | 2 | FMN2, HERC2 |
| glycerolipid biosynthetic process (GO:0045017) | 4.53 | 2 | PGAP1, PIGG |
| protein N-linked glycosylation (GO:0006487) | 5.65 | 2 | TUSC3, ST3GAL3 |
| cellular amino acid metabolic process (GO:0006520) | 4.22 | 2 | GPT2, HNMT |
| positive regulation of apoptotic process (GO:0043065) | 3.38 | 2 | CRADD, GRIK2 |
| negative regulation of apoptotic process (GO:0043066) | 3.04 | 2 | FMN2, GRIK2 |
| regulation of ion transport (GO:0043269) | 3.4 | 2 | CRBN, ANK3 |
| tRNA modification (GO:0006400) | 5.59 | 2 | NSUN2, ADAT3 |
| negative regulation of programmed cell death (GO:0043069) | 3.02 | 2 | FMN2, GRIK2 |
| positive regulation of programmed cell death (GO:0043068) | 3.38 | 2 | CRADD, GRIK2 |
| negative regulation of mitotic cell cycle (GO:0045930) | 4.45 | 2 | CRADD, FBXO31 |
| Golgi vesicle transport (GO:0048193) | 4.07 | 2 | LMAN2L, ANK3 |
| cellular protein localization (GO:0034613) | 3.11 | 2 | ANK3, GRIK2 |
| positive regulation of intracellular protein transport (GO:0090316) | 4.19 | 2 | HNMT, ANK3 |
| cellular process involved in reproduction in multicellular organism (GO:0022412) | 4.3 | 2 | FMN2, NSUN2 |
| protein lipidation (GO:0006497) | 5.38 | 2 | PGAP1, PIGG |
| actin filament organization (GO:0007015) | 4.54 | 2 | FMN2, KPTN |
| cytoskeleton organization (GO:0007010) | 3.22 | 2 | FMN2, ANK3 |
| cell cycle checkpoint (GO:0000075) | 4.79 | 2 | NSUN2, FBXO31 |
| regulation of cell cycle (GO:0051726) | 2.93 | 2 | CRADD, FBXO31 |
| regulation of cell cycle G1/S phase transition (GO:1902806) | 4.74 | 2 | CRADD, FBXO31 |
| tRNA metabolic process (GO:0006399) | 4.52 | 2 | NSUN2, ADAT3 |
| single-organism organelle organization (GO:1902589) | 2.68 | 2 | FMN2, ANK3 |
| RNA processing (GO:0006396) | 3.01 | 2 | NSUN2, ADAT3 |